Endothelial Injury in Endotoxin-Induced Acute Renal Failure

内毒素引起的急性肾衰竭中的内皮损伤

基本信息

  • 批准号:
    8440351
  • 负责人:
  • 金额:
    $ 31.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-01 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Acute renal failure affects approximately 5% of all hospitalized patients, causing great morbidity and mortality, and commonly results from sepsis. Preliminary data indicate that LPS-induced ARF, a model of septic renal dysfunction, depends on the action of TNF on its receptor TNFR1 in the kidney, and is associated with renal endothelial apoptosis, inflammation, and vascular leak both in vivo and in vitro. Specific Aim 1 will use primary culture of mouse renal endothelial cells (ECs) to determine the mechanisms of TNF-induced endothelial barrier dysfunction, via use of pharmacologic inhibitors and an siRNA approach, and will study the effect on cytoskeletal disruption caused by TNF. Specific Aim 2 will determine the role of this endothelial barrier dysfunction in the course of LPS-induced acute renal failure (ARF) using transgenic mice overexpressing and deficient in the endothelial isoform of myosin light chain kinase (MLCK). Sphingosine-1-phosphate analogues, which maintain endothelial barrier integrity, will also be administered to determine the effect on LPS-induced ARF. Renal cross-transplantation will be used as a tool to define the contribution of renal as opposed to systemic endothelial injury, and chronically implanted blood pressure and renal flowprobe devices will allow real-time measurement of intrarenal hemodynamics in response to the above manipulations in the setting of endotoxemia. Specific Aim 3 will test the hypothesis that TNF-induced caspase activation amplifies renal endothelial inflammation, and will define mechanisms through which this cross-talk occurs, which may involve MLCK and other cytoskeletal events. Specific Aim 4 will use endothelial-specific knockout mice lacking caspase-8, and endothelial-specific transgenic mice with nonfunctional NF-?B, to distinguish the respective contributions of endothelial apoptosis and inflammation to the outcome of LPS-induced ARF. Together, this project will develop tools which should allow greater understanding of the importance and mechanism of endothelial injury and its role in septic ARF.
描述(由申请人提供):急性肾衰竭影响约5%的住院患者,造成很高的发病率和死亡率,通常由败血症引起。初步数据表明,lps诱导的ARF是一种脓毒性肾功能障碍模型,依赖于TNF对肾脏中其受体TNFR1的作用,并且在体内和体外均与肾内皮细胞凋亡、炎症和血管泄漏有关。特异性目的1将使用小鼠肾内皮细胞(ECs)的原代培养,通过使用药物抑制剂和siRNA方法来确定TNF诱导的内皮屏障功能障碍的机制,并将研究TNF引起的细胞骨架破坏的影响。特异性目的2将利用肌球蛋白轻链激酶(MLCK)内皮异构体过表达和缺乏的转基因小鼠,确定这种内皮屏障功能障碍在lps诱导的急性肾功能衰竭(ARF)过程中的作用。维持内皮屏障完整性的鞘氨醇-1-磷酸类似物也将被用于确定对lps诱导的ARF的影响。肾交叉移植将作为一种工具来定义肾脏的贡献,而不是全身内皮损伤,长期植入血压和肾血流探头装置将允许实时测量肾内血流动力学,以响应上述内毒素血症的操作。特异性Aim 3将验证tnf诱导的caspase激活放大肾内皮炎症的假设,并将确定这种串扰发生的机制,这可能涉及MLCK和其他细胞骨架事件。特异性Aim 4将使用缺乏caspase-8的内皮特异性敲除小鼠和无功能NF-?B,区分内皮细胞凋亡和炎症对lps诱导的ARF结局的各自贡献。总之,该项目将开发工具,以便更好地了解内皮损伤的重要性和机制及其在脓毒性ARF中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PATRICK N CUNNINGHAM其他文献

PATRICK N CUNNINGHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PATRICK N CUNNINGHAM', 18)}}的其他基金

Endothelial Injury in Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭中的内皮损伤
  • 批准号:
    7785146
  • 财政年份:
    2010
  • 资助金额:
    $ 31.21万
  • 项目类别:
Endothelial Injury in Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭中的内皮损伤
  • 批准号:
    8265931
  • 财政年份:
    2010
  • 资助金额:
    $ 31.21万
  • 项目类别:
Endothelial Injury in Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭中的内皮损伤
  • 批准号:
    8618895
  • 财政年份:
    2010
  • 资助金额:
    $ 31.21万
  • 项目类别:
Endothelial Injury in Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭中的内皮损伤
  • 批准号:
    8037170
  • 财政年份:
    2010
  • 资助金额:
    $ 31.21万
  • 项目类别:
Pathogenesis of Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭的发病机制
  • 批准号:
    6892359
  • 财政年份:
    2002
  • 资助金额:
    $ 31.21万
  • 项目类别:
Pathogenesis of Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭的发病机制
  • 批准号:
    6623057
  • 财政年份:
    2002
  • 资助金额:
    $ 31.21万
  • 项目类别:
Pathogenesis of Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭的发病机制
  • 批准号:
    6460805
  • 财政年份:
    2002
  • 资助金额:
    $ 31.21万
  • 项目类别:
Pathogenesis of Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭的发病机制
  • 批准号:
    6743768
  • 财政年份:
    2002
  • 资助金额:
    $ 31.21万
  • 项目类别:
Pathogenesis of Endotoxin-Induced Acute Renal Failure
内毒素引起的急性肾衰竭的发病机制
  • 批准号:
    7059868
  • 财政年份:
    2002
  • 资助金额:
    $ 31.21万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了